期刊文献+
共找到776篇文章
< 1 2 39 >
每页显示 20 50 100
白细胞介素1受体颉颃剂抑制脂多糖促奶牛外周血单个核细胞氧化应激损伤作用的研究
1
作者 郭咏梅 齐敬宇 +2 位作者 闫素梅 赵艳丽 郭晓宇 《饲料工业》 CAS 北大核心 2024年第4期100-105,共6页
试验以脂多糖(LPS)为刺激源,以细胞活力、抗氧化指标和炎症因子为判断指标,探讨白细胞介素1受体颉颃剂(IL-1Ra)通过抑制白细胞介素1β(IL-1β)的活性,对LPS诱导外周血单个核细胞(Peripheral blood mononuclear cells,PBMCs)氧化损伤的... 试验以脂多糖(LPS)为刺激源,以细胞活力、抗氧化指标和炎症因子为判断指标,探讨白细胞介素1受体颉颃剂(IL-1Ra)通过抑制白细胞介素1β(IL-1β)的活性,对LPS诱导外周血单个核细胞(Peripheral blood mononuclear cells,PBMCs)氧化损伤的缓解作用。试验采用单因子完全随机设计,PBMCs被随机分为7个组(每组6个重复),分别给予不同的处理:第1组是阴性对照组(Neg组),完全培养基培养30 h;第2组损伤组(Dam组),是在完全培养基中培养6 h后,再经10μg/mL的LPS工作液培养24 h;第3至7组(R0.25、R0.5、R1、R5组和R10组)细胞分别经浓度为0.25、0.5、1、5、10 ng/mL的IL-1Ra培养6 h,接着经10μg/mL的LPS工作液培养24 h。结果表明:与Neg组相比,Dam组的细胞活力、抗氧化相关酶[包括总抗氧化能力(T-AOC)以及总超氧化物歧化酶(T-SOD)、过氧化氢酶(CAT)、谷胱甘肽过氧化物酶(GPx)和硫氧还蛋白还原酶(TrxR)]的活性显著降低,丙二醛(MDA)浓度、炎症因子白细胞介素-6(IL-6)和IL-1β含量以及诱导型一氧化氮合酶(iNOS)活性、一氧化氮(NO)含量均显著升高(P≤0.05)。与Dam组相比,R1组显著逆转了氧化损伤引起的上述抗氧化活性的降低和炎症因子浓度的升高,其他IL-1Ra处理组对上述指标的逆转效果不同程度地低于R1组(P≤0.05)。上述结果说明,LPS通过诱发PBMCs产生大量IL-1β进而导致细胞氧化损伤,IL-1Ra剂量依赖性地缓解了LPS引起的氧化损伤,添加剂量以1 ng/mL为宜。 展开更多
关键词 奶牛外周血单个核细胞 氧化应激 剂量依赖性 白细胞介素1受体颉颃剂 预保护作用
下载PDF
Pharmacophore-guided design,synthesis and evaluation of quinazoline-arylpiperazines as newα_1-adrenoceptor antagonists 被引量:3
2
作者 Hao Fang Min Yong Li Lin Xia 《Chinese Chemical Letters》 SCIE CAS CSCD 2007年第1期41-44,共4页
A series of arylpiperazinesquinazoline-2,4-diamine compounds were designed and synthesized based on pharmacophore for m-selective α1-adrenoceptor antagonists and 3D chemical database searching. The in vitro functiona... A series of arylpiperazinesquinazoline-2,4-diamine compounds were designed and synthesized based on pharmacophore for m-selective α1-adrenoceptor antagonists and 3D chemical database searching. The in vitro functional analysis showed that compounds 9 and 14 showed better and similar α1-AR antagonistic activity compared with prazosin. 展开更多
关键词 α1-Adrcnoceptor antagonistS Pharmacophore-guided design
下载PDF
Constructing Biophore of Uroselective α1-Adrenoceptor antagonist 被引量:3
3
作者 FANGHao LUJing-fen XIALin 《Journal of Chinese Pharmaceutical Sciences》 CAS 2003年第4期188-191,共4页
Aim The biophore of uroselective α1-adrenoceptor antagonist was studied by using Apex-3D software on an O2 Silicon Graphics Computer Station. Methods Five known antagonism (Indoramin, GG-818, RS100975, R-YM12167,and ... Aim The biophore of uroselective α1-adrenoceptor antagonist was studied by using Apex-3D software on an O2 Silicon Graphics Computer Station. Methods Five known antagonism (Indoramin, GG-818, RS100975, R-YM12167,and KMD-3213), which possess both good selectivity and high affinities to prostate and α1-AR subtype, were chosen for htilding the biophore. Using an autoraatic filtering software for obtaining reasonable biophorcs, the filter parameters were selected: P (probability) >0.8, active (number of active compounds)≥4, and size (descriptor center)≥3. Results Three biophorcs conformed to the requirements, each of whom contained a basic center, an aromatic ring center and H-site according to the structure-activity relationships of known α1-adrenoceptor antagonist. Conclusion The biophore model developed by computer simulation with Apex-3D software can be used to design and synthesize a new α1-adrenoeeptor antagonist with high activity and low side effect. 展开更多
关键词 α1-肾上腺素能受体拮抗剂 生源体 吲哚哌胺 超选择性
下载PDF
波塞冬1组患者重复周期应用早卵泡期长效长方案和拮抗剂方案的疗效比较及自身对照研究
4
作者 明子琳 李婉晴 +1 位作者 唐志霞 洪名云 《生殖医学杂志》 CAS 2024年第1期8-16,共9页
目的探讨早卵泡期长效长方案和拮抗剂方案在波塞冬1组患者重复周期中的应用疗效及优化策略。方法选择2018年6月至2022年6月于安徽省妇幼保健院生殖中心行体外受精(IVF)/卵胞浆内单精子注射(ICSI)治疗、采用常规控制性促排卵(COH)方案发... 目的探讨早卵泡期长效长方案和拮抗剂方案在波塞冬1组患者重复周期中的应用疗效及优化策略。方法选择2018年6月至2022年6月于安徽省妇幼保健院生殖中心行体外受精(IVF)/卵胞浆内单精子注射(ICSI)治疗、采用常规控制性促排卵(COH)方案发生非预期卵巢低反应(uPOR)、且助孕失败后再次助孕的波塞冬1组患者286例为研究对象,根据重复周期COH方案不同分为早卵泡期长效长方案组(简称早长方案组,n=119例)和拮抗剂方案组(n=167例),比较两组实验室指标及临床妊娠结局;并将其中前后两个周期均采用相同COH方案的124例患者分为双早长方案组(n=70例)和双拮抗剂方案组(n=54例),采用自身对照研究分析两组临床资料。结果(1)再次COH周期早长方案组与拮抗剂方案组患者间基础资料比较无统计学差异(P>0.05)。早长方案组促性腺激素(Gn)总量、Gn天数、HCG日E_(2)水平、获卵数、可用胚胎数及优质胚胎数均显著高于拮抗剂方案组(P<0.05),HCG日LH水平显著低于拮抗剂方案组(P<0.05),其鲜胚种植率、鲜胚临床妊娠率及累积妊娠率较拮抗剂方案组有升高趋势,但无统计学差异(P>0.05);两组患者间周期取消率、中重度卵巢过度刺激综合征(OHSS)发生率、HCG日孕酮(P)水平、HCG日内膜厚度、再次uPOR发生率及早期流产率等比较均无统计学差异(P>0.05)。(2)双早长方案组的自身对照比较结果显示,再次早长方案组Gn启动剂量、LH添加量、HCG日E_(2)水平、获卵数、可用胚胎数、优质胚胎数、正常受精率、优质胚胎率、鲜胚种植率和临床妊娠率均显著高于首次早长方案组(P<0.05),早期流产率显著低于首次早长方案组(P<0.05)。(3)双拮抗剂方案组的自身对照比较结果显示,再次拮抗剂方案组Gn启动剂量、LH添加量、获卵数、可用胚胎数、优质胚胎数、鲜胚种植率及临床妊娠率等均显著高于首次拮抗剂方案组(P<0.05)。结论对于波塞冬1组患者来说,早卵泡期长效长方案和拮抗剂方案均可作为重复周期的促排卵方案;从获卵数及鲜胚临床妊娠结局考虑,早卵泡期长效长方案优于拮抗剂方案;从经济成本考虑,拮抗剂方案优于早卵泡期长效长方案。重复周期可根据两个方案的劣势采取优化措施来改善患者对于促排卵方案的反应性及卵母细胞质量和数量等问题,从而改善IVF/ICSI预后。 展开更多
关键词 非预期卵巢低反应 波塞冬1 早卵泡期长效长方案 拮抗剂方案 自身对照研究
下载PDF
白细胞介素-1受体拮抗剂与骨关节炎及亚型的孟德尔随机化研究
5
作者 陈继鑫 周沁心 +3 位作者 郭天赐 余伟杰 叶云天 刘爱峰 《医学研究杂志》 2024年第4期46-51,共6页
目的 采用双样本孟德尔随机化(Mendelian randomization, MR)的研究方法,评估白细胞介素-1受体拮抗剂(interleukin-1 receptor antagonist, IL-1RA)与骨关节炎及亚型骨关节炎的因果关系。方法 IL-1RA与骨关节炎、膝骨关节炎、髋骨关节... 目的 采用双样本孟德尔随机化(Mendelian randomization, MR)的研究方法,评估白细胞介素-1受体拮抗剂(interleukin-1 receptor antagonist, IL-1RA)与骨关节炎及亚型骨关节炎的因果关系。方法 IL-1RA与骨关节炎、膝骨关节炎、髋骨关节炎的单核苷酸多态性位点(single nucleotide polymorphism, SNP)来自公开的全基因组关联研究汇总数据集,选取密切相关的SNP作为工具变量(instrumental variable, IV)。筛选敏感度试验,MR多效性残差和采用离群值检验来验证所识别的IV的异质性和多效性。采用5种不同的模型,包括逆方差加权模型(inverse-variance weighted, IVW)、加权中值估计模型、基于加权模型的方法、MR-Egger回归和简单众数法进行MR分析。结果 研究不存在异质性。固定效应模型的IVW显示,IL-1RA与骨关节炎(OR=1.06,95%CI:1.01~1.11)、膝骨关节炎(OR=1.07,95%CI:1.01~1.13)之间有显著的因果关系,与髋骨关节炎之间具有相关性,因果关系不显著。敏感度分析显示,研究结果具有稳健性。结论 MR研究支持IL-1RA水平与骨关节炎、膝骨关节炎的发病风险具有因果关系。 展开更多
关键词 白细胞介素-1受体拮抗剂 骨关节炎 孟德尔随机化研究
下载PDF
血清iNOS、TREM-1、IL-1Ra表达与细菌感染性肠炎患者病情严重程度的关系及其临床意义研究
6
作者 梁丹红 梁民联 +2 位作者 黄换桂 王家华 郑一沣 《中国现代医学杂志》 CAS 2024年第11期72-77,共6页
目的探究细菌感染性肠炎患者血清诱导型一氧化氮合酶(iNOS)、髓样细胞触发受体-1(TREM-1)和白细胞介素-1受体拮抗剂(IL-1Ra)表达的临床意义。方法前瞻性选取2021年2月—2023年2月广州中医药大学东莞医院收治的120例细菌感染性肠炎患者... 目的探究细菌感染性肠炎患者血清诱导型一氧化氮合酶(iNOS)、髓样细胞触发受体-1(TREM-1)和白细胞介素-1受体拮抗剂(IL-1Ra)表达的临床意义。方法前瞻性选取2021年2月—2023年2月广州中医药大学东莞医院收治的120例细菌感染性肠炎患者为研究对象。采集患者粪便标本,分析感染病原菌的病原学特点;根据病情严重程度将患者分为轻度组28例、中度组79例和重度组13例。另选取同期本院体检的健康体检者60例为对照组。比较各组炎症因子[血清降钙素原(PCT)、C反应蛋白(CRP)]、iNOS、TREM-1、IL-1Ra水平;采用Pearson相关分析iNOS、TREM-1、IL-1Ra与炎症因子水平的相关性;采用受试者工作特征(ROC)曲线分析血清iNOS、TREM-1、IL-1Ra对重度细菌感染性肠炎的诊断价值。结果120例细菌感染性肠炎患者共检出176株病原菌,其中氏阳性菌38株(21.59%),革兰阴性菌138株(78.41%)。4组血清PCT、CRP、iNOS、TREM-1、IL-1Ra水平比较,差异均有统计学意义(P<0.05);重度组、中度组、轻度组和对照组依次降低(P<0.05)。Pearson相关性分析结果显示,iNOS、TREM-1、IL-1Ra水平与PCT、CRP水平均呈正相关(P<0.05)。ROC曲线分析结果显示,iNOS最佳截断值为50.07 ng/L,诊断重度细菌感染性肠炎的敏感性和特异性分别为76.92%(95%CI:0.462,0.950)、81.31%(95%CI:0.726,0.882);TREM-1最佳截断值为70.11 pg/mL,诊断的敏感性和特异性分别为84.62%(95%CI:0.546,0.981)、85.05%(95%CI:0.769,0.912);IL-1Ra最佳截断值为271.75 ng/L,诊断的敏感性和特异性分别为92.31%(95%CI:0.640,0.998)、66.36%(95%CI:0.566,0.752)。结论细菌感染性肠炎患者血清iNOS、TREM-1、IL-1Ra表达升高,与患者病情严重程度存在相关性;三者在诊断重度细菌感染性肠炎方面具有良好的诊断价值,或可作为临床评估细菌感染性肠炎病情的潜在指标。 展开更多
关键词 细菌感染性肠炎 诱导型一氧化氮合酶 髓样细胞触发受体-1 IL-1受体拮抗剂 预测价值
下载PDF
Design and Synthesis of Novel Aryloxyalkyl-arylpiperazine Derivatives as α_(1A)-Adrenoceptor Antagonists
7
作者 HaoFANG MinYongLI +2 位作者 LinXIA ZhenZhouJIANG ZhiZhenLU 《Chinese Chemical Letters》 SCIE CAS CSCD 2005年第4期445-448,共4页
A series of 1-[2-(substituted phenoxy)ethyl]-4-(2-methoxyphenyl)-piperazine deriva- tives have been synthesized. The radioligand receptor binding assay indicated that most of them bind with α1-adrenoceptor specific... A series of 1-[2-(substituted phenoxy)ethyl]-4-(2-methoxyphenyl)-piperazine deriva- tives have been synthesized. The radioligand receptor binding assay indicated that most of them bind with α1-adrenoceptor specifically, and one of the compound possessed subtype A selectivity. 展开更多
关键词 Α1-adrenoceptor antagonist aryloxyalkyl-arylpiperazine.
下载PDF
神经激肽1受体拮抗剂替代地塞米松二联方案预防中度致吐风险化疗所致恶心呕吐的随机对照试验
8
作者 聂吴仪 周娟 +2 位作者 程东海 王浩强 谢波 《海军军医大学学报》 CAS CSCD 北大核心 2024年第4期462-469,共8页
目的比较神经激肽1(NK-1)受体拮抗剂(RA)联合托烷司琼与地塞米松联合托烷司琼预防中度致吐风险化疗所致恶心呕吐(MEC-CINV)的效果。方法采用非劣效性试验设计,将中国人民解放军南部战区总医院肿瘤科2021年4月至2022年1月满足条件的拟接... 目的比较神经激肽1(NK-1)受体拮抗剂(RA)联合托烷司琼与地塞米松联合托烷司琼预防中度致吐风险化疗所致恶心呕吐(MEC-CINV)的效果。方法采用非劣效性试验设计,将中国人民解放军南部战区总医院肿瘤科2021年4月至2022年1月满足条件的拟接受中度致吐风险化疗的肿瘤患者按照随机数字表法分为NK-1 RA组和地塞米松组。NK-1 RA组患者采用NK-1 RA(阿瑞匹坦或福沙匹坦)+托烷司琼二联止吐方案,地塞米松组采用托烷司琼+地塞米松标准二联止吐方案。主要评价指标为总观察期(0~120 h)、延迟期(24~120 h)、急性期(24 h内)的呕吐完全缓解(CR)率,次要评价指标为各期恶心完全控制(CC)率及恶心呕吐总缓解(TR)率,安全性指标为止吐药物的不良反应(包括乏力、便秘、呃逆、失眠等症状指标,以及白细胞计数减少、中性粒细胞计数减少、血红蛋白下降、血小板计数减少、丙氨酸转氨酶和/或天冬氨酸转氨酶升高、血肌酐升高等实验室指标异常)。采用差异性检验(检验水准为0.05)和非劣效性检验(非劣效性界值为15%,检验水准为0.025)比较两组的干预效果。结果最终共有101例患者全程参与本研究,其中NK-1 RA组51例,地塞米松组50例。NK-1 RA组和地塞米松组总观察期呕吐CR率分别为58.8%(30/51)和56.0%(28/50),非劣效性检验无统计学意义[P_(非劣效)=0.035,率差(RD)=2.80%,95%CI-16.5%~22.1%];急性期呕吐CR率分别为80.4%(41/51)和78.0%(39/50),非劣效性检验有统计学意义(P_(非劣效)=0.016,RD=2.40%,95%CI-13.4%~18.2%);延迟期呕吐CR率分别为62.7%(32/51)和58.0%(29/50),非劣效性检验有统计学意义(P_(非劣效)=0.021,RD=4.70%,95%CI-14.4%~23.8%)。NK-1 RA组各期恶心CC率略高于地塞米松组,非劣效性检验有统计学意义(均P_(非劣效)<0.025)。两组间各安全性指标差异无统计学意义(均P>0.05)。结论在MEC-CINV患者中,NK-1 RA联合托烷司琼的二联止吐方案对恶心呕吐的控制效果非劣效于地塞米松联合托烷司琼标准二联止吐方案,且安全性良好。 展开更多
关键词 中度致吐风险化疗 恶心 呕吐 5-羟色胺3受体拮抗剂 神经激肽1受体拮抗剂 地塞米松
下载PDF
解淀粉芽孢杆菌GSBa-1对5种果实采后贮藏品质的影响
9
作者 卢清琛 张敏 +5 位作者 刘帮迪 郭淑珍 张照香 孙静 高海娜 刘贵巧 《食品研究与开发》 CAS 2024年第10期59-68,共10页
为探究解淀粉芽孢杆菌GSBa-1(Bacillus amyloliquefaciens GSBa-1)对不同果实的成熟和腐烂抑制作用,选用冬枣、软枣猕猴桃、芒果、甜瓜和梨作为研究对象,将果实用1×10^(8)cfu/mL的解淀粉芽孢杆菌GSBa-1菌液浸泡15s,对常温贮藏期间... 为探究解淀粉芽孢杆菌GSBa-1(Bacillus amyloliquefaciens GSBa-1)对不同果实的成熟和腐烂抑制作用,选用冬枣、软枣猕猴桃、芒果、甜瓜和梨作为研究对象,将果实用1×10^(8)cfu/mL的解淀粉芽孢杆菌GSBa-1菌液浸泡15s,对常温贮藏期间5种果实病情指数、硬度、相对电导率、呼吸强度、总酚含量等指标进行测定。结果表明:解淀粉芽孢杆菌GSBa-1可以分别降低冬枣和芒果呼吸强度和乙烯释放量峰值:25.78%、10.93%和11.97%、2.92%,并将梨呼吸强度和乙烯释放量出现峰值的时间延迟5d,有效维持果实硬度,延缓可滴定酸降解速率和转色,降低果实相对电导率;与未经解淀粉芽孢杆菌GSBa-1处理的果实相比,有效诱导了芒果和冬枣总酚含量的增加,提高芒果和冬枣DPPH自由基清除能力,在第4天,将芒果和冬枣病情指数降低至0.2、0,由于贮藏时间较短,梨果实并没有出现发病。但该菌株并不能降低甜瓜和软枣猕猴桃的病情指数和相对电导率。结论:解淀粉芽孢杆菌GSBa-1可以延缓冬枣、芒果和梨的成熟衰老,抑制冬枣和芒果的腐烂,可以有效对冬枣和芒果进行保鲜,对甜瓜和软枣猕猴桃保鲜效果不理想。 展开更多
关键词 解淀粉芽孢杆菌GSBa-1 生防菌 拮抗 保鲜 贮藏品质
下载PDF
非酒精性脂肪性肝病患者血清IL-1RA、CTRP13和CK-18水平变化及其临床意义探讨
10
作者 高洋 张静 卢宣霖 《实用肝脏病杂志》 CAS 2024年第2期185-188,共4页
目的探讨非酒精性脂肪性肝病(NAFLD)患者血清白细胞介素-1受体拮抗剂(IL-1RA)、补体C1q肿瘤坏死因子相关蛋白13(CTRP13)和细胞角蛋白18(CK-18)水平变化及其临床意义。方法2021年1月~2023年1月我院收治的67例NAFLD患者和55例健康体检者,... 目的探讨非酒精性脂肪性肝病(NAFLD)患者血清白细胞介素-1受体拮抗剂(IL-1RA)、补体C1q肿瘤坏死因子相关蛋白13(CTRP13)和细胞角蛋白18(CK-18)水平变化及其临床意义。方法2021年1月~2023年1月我院收治的67例NAFLD患者和55例健康体检者,经肝活检诊断肝脏脂肪变性分级,采用ELISA法检测血清IL-1RA、CTRP13和CK-18水平。应用多元Logistic回归分析危险因素。结果NAFLD组血清IL-1RA和CTRP13水平分别为(328.6±54.3)pg/ml和(2634.2±397.5)pg/ml,显著低于健康人组【分别为(673.1±125.4)pg/ml和(3425.7±423.8)pg/ml,P<0.05】,而血清CK-18水平为(15.2±3.1)ng/ml,显著高于健康人组【(3.9±0.7)ng/ml,P<0.05】;17例F3级肝脂肪变性患者血清IL-1RA和CTRP13水平分别为(256.3±47.6)pg/ml和(2056.3±308.4)pg/ml,显著低于29例F1级患者【分别为(388.3±59.4)pg/ml和(3071.5±409.3)pg/ml,P<0.05】或21例F2级患者【分别为(304.7±50.1)pg/ml和(2498.1±374.2)pg/ml,P<0.05】,而血清CK-18水平为(23.4±4.7)ng/ml,显著高于F1级患者【(8.1±1.3)ng/ml,P<0.05】或F2级患者【(18.5±2.9)ng/ml,P<0.05】;F3级肝脂肪变性患者肥胖、合并糖尿病、合并高脂血症、有代谢综合征家族史、血清IL-1RA≥256.5pg/ml、CTRP13≥2056.5pg/ml和CK-18≥21.6 ng/ml占比分别为70.6%、76.5%、88.2%、70.6%、35.3%、35.3%和70.6%,与50例F1/F2级的38.0%、42.0%、40.0%、30.0%、92.0%、80.0%和10.0%比,差异显著(P<0.05);多因素Logistic回归分析表明,肥胖【OR(95%)为2.0(1.1~3.6)】、合并糖尿病【OR(95%)为2.1(1.1~4.1)】、合并高脂血症【OR(95%)为1.6(1.0~2.6)】、IL-1RA【OR(95%)为0.5(0.3~0.9)】、CTRP13【OR(95%)为0.5(0.3~0.9)】和CK-18【OR(95%)为1.7(1.2~2.5)】为影响NAFLD患者肝脏脂肪变性程度的危险因素(P<0.05)。结论NAFLD患者血清IL-1RA、CTRP13和CK-18水平异常变化可能为评估肝脏脂肪变性程度提供一定的依据。 展开更多
关键词 非酒精性脂肪性肝病 白细胞介素-1受体拮抗剂 补体C1q肿瘤坏死因子相关蛋白13 细胞角蛋白18 临床意义
下载PDF
白细胞介素-1受体拮抗剂对脂多糖诱导的奶牛乳腺上皮细胞氧化损伤的保护作用 被引量:1
11
作者 郭咏梅 石惠宇 +3 位作者 闫素梅 史彬林 郭晓宇 赵艳丽 《动物营养学报》 CAS CSCD 北大核心 2023年第7期4596-4603,共8页
本试验以脂多糖(LPS)作为应激源,诱导奶牛乳腺上皮细胞(BMEC)氧化损伤,旨在探究白细胞介素-1受体拮抗剂(IL-1Ra)对LPS诱导的BMEC氧化损伤的保护作用,并确定抑制细胞氧化损伤的适宜IL-1Ra浓度。第3代贴壁生长的BMEC被随机分为12个组:对照... 本试验以脂多糖(LPS)作为应激源,诱导奶牛乳腺上皮细胞(BMEC)氧化损伤,旨在探究白细胞介素-1受体拮抗剂(IL-1Ra)对LPS诱导的BMEC氧化损伤的保护作用,并确定抑制细胞氧化损伤的适宜IL-1Ra浓度。第3代贴壁生长的BMEC被随机分为12个组:对照组(无LPS,无IL-1Ra)、LPS组(1.0μg/mL LPS)、单独添加IL-1Ra(0.25、0.50、1.00、5.00和10.00 ng/mL)组、同时添加IL-1Ra与LPS(0.25 ng/mL IL-1Ra+1.0μg/mL LPS、0.50 ng/mL IL-1Ra+1.0μg/mL LPS、1.00 ng/mL IL-1Ra+1.0μg/mL LPS、5.00 ng/mL IL-1Ra+1.0μg/mL LPS、10.00 ng/mL IL-1Ra+1.0μg/mL LPS)组,每组设6个重复。不同处理的工作液作用于细胞6 h后,测定细胞相对增殖率(RGR),并且收集细胞和培养液测定抗氧化指标和炎性因子含量。结果显示:与对照组相比,单独添加不同浓度的IL-1Ra对RGR、谷胱甘肽过氧化物酶1(GPx1)、硫氧还蛋白还原酶1(TrxR1)、过氧化氢酶(CAT)活性与总抗氧化能力(T-AOC)以及丙二醛(MDA)、活性氧(ROS)、肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)、诱导性一氧化氮合酶(iNOS)、一氧化氮(NO)含量均无显著影响(P>0.05);但是,单独添加不同浓度IL-1Ra对白细胞介素-1(IL-1)的生成有显著的抑制效果(P<0.05)。与LPS组相比,同时添加LPS和1.00 ng/mL IL-1Ra能显著提高RGR(P<0.05),显著增加GPx1和超氧化物歧化酶(SOD)活性与T-AOC,并显著降低IL-1、IL-6、TNF-α、MDA、ROS、iNOS、NO含量(P<0.05)。结果提示,单独添加IL-1Ra可以专一性的抑制BMEC内IL-1的产生,对细胞氧化应激的影响不显著;LPS加速了BMEC氧化还原水平的失衡,IL-1Ra可有效抑制LPS诱导的细胞氧化损伤,且IL-1Ra的适宜作用浓度为1.00 ng/mL。 展开更多
关键词 奶牛乳腺上皮细胞 脂多糖 白细胞介素-1受体拮抗剂
下载PDF
β_(1)肾上腺素能受体Arg389Gly基因多态性与心肌梗死后心室重构的关系
12
作者 李俊萍 郭晓华 陈强 《当代医学》 2023年第20期98-103,共6页
目的探讨β_(1)肾上腺素能受体(β_(1)-AR)Arg389Gly基因多态性与心肌梗死后心室重构的关系。方法选取2014年1月至2015年12月本院收治的120例ST段抬高心肌梗死患者作为研究对象,采用聚合酶链式反应-限制性酶片段长度多态性(PCR-RFLP)技... 目的探讨β_(1)肾上腺素能受体(β_(1)-AR)Arg389Gly基因多态性与心肌梗死后心室重构的关系。方法选取2014年1月至2015年12月本院收治的120例ST段抬高心肌梗死患者作为研究对象,采用聚合酶链式反应-限制性酶片段长度多态性(PCR-RFLP)技术检测患者β_(1)-ARArg389Gly多态性位点基因型,采用超声心动图测量左心室舒张末期内径(LVDD)及左心室射血分数(LVEF)。分析β_(1)-ARArg389Gly多态性基因型频率分布,比较不同β_(1)-ARArg389Gly基因型患者一般情况及LVDD、LVEF。结果Arg389纯合子患者与Gly389等位基因携带患者年龄、性别、吸烟、高血压、糖尿病、前壁心肌梗死、梗死相关血管开通比例及总胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)水平比较差异无统计学意义。梗死后1周,Arg389纯合子患者与Gly389等位基因携带患者LVDD、LVEF比较差异无统计学意义;梗死后6个月,Arg389纯合子患者与Gly389等位基因携带患者LVDD均长于梗死后1周,LVEF均低于梗死后1周,但Arg389纯合子患者LVDD短于Gly389等位基因携带患者,LVEF高于Gly389等位基因携带患者,差异有统计学意义(P<0.05)。结论β_(1)-AR Arg389Gly基因多态性与心肌梗死后左心室重构有关,临床应及早给予患者再灌注治疗、开通梗死相关血管,以改善患者预后。 展开更多
关键词 β_(1)肾上腺素能受体 基因多态性 心室重构
下载PDF
辛芩颗粒联合H_(1)受体拮抗剂治疗变应性鼻炎有效性及安全性Meta分析 被引量:1
13
作者 郑诗凯 陆一慧 陈芷新 《新中医》 CAS 2023年第7期48-52,共5页
目的:系统评价辛芩颗粒联合H_(1)受体拮抗剂治疗变应性鼻炎的有效性及安全性。方法:计算机检索中国知网(CNKI)、中国生物医学文献数据库(CBM)、万方数据库(Wanfang)、维普中文期刊(VIP)、Cochrane Library、Embase、PubMed数据库中有关... 目的:系统评价辛芩颗粒联合H_(1)受体拮抗剂治疗变应性鼻炎的有效性及安全性。方法:计算机检索中国知网(CNKI)、中国生物医学文献数据库(CBM)、万方数据库(Wanfang)、维普中文期刊(VIP)、Cochrane Library、Embase、PubMed数据库中有关辛芩颗粒联合H_(1)受体拮抗剂治疗变应性鼻炎的随机对照试验。使用RevMan5.3和Stata15.0软件进行Meta分析。结果:共纳入7篇文献,涉及患者683例。Meta分析显示,辛芩颗粒联合H_(1)受体拮抗剂治疗变应性鼻炎总有效率[RR=1.18,95%CI(1.11,1.25),P<0.0001]高于对照组;敏感性分析提示辛芩颗粒联合H_(1)受体拮抗剂治疗变应性鼻炎的总有效率结果稳定。辛芩颗粒联合H_(1)受体拮抗剂治疗变应性鼻炎的复发率[RR=0.27,95%CI(0.12,0.61),P=0.001]低于对照组,2组不良反应发生率比较,差异无统计学意义[RR=0.61,95%CI(0.26,1.40),P=0.24]。结论:辛芩颗粒联合H_(1)受体拮抗剂治疗变应性鼻炎的临床疗效优于单纯的H_(1)受体拮抗剂治疗,安全性较好。 展开更多
关键词 变应性鼻炎 辛芩颗粒 H_(1)受体拮抗剂 META分析
下载PDF
Effects of AT1 receptor antagonist,Iosartan,on rat hepatic fibrosis induced by CCl_4 被引量:42
14
作者 Hong Shan Wei Ding Guo Li Han Ming Lu Yu Tao Zhan Zhi Rong Wang Xin Huang Jing Zhang Ji Lin Cheng Qin Fang Xu Department of Gastroenterology,Xinhua Hospital,Shanghai Second Medical University,Shanghai 200092,China 《World Journal of Gastroenterology》 SCIE CAS CSCD 2000年第4期540-545,共6页
AIM To investigate effect of losartan,an AT1receptor antagonist,on hepatic fibrosis induced byCCl<sub>;</sub>and to determine whether or not AT1receptors are expressed on hepatic stellate cells,METHODS AND... AIM To investigate effect of losartan,an AT1receptor antagonist,on hepatic fibrosis induced byCCl<sub>;</sub>and to determine whether or not AT1receptors are expressed on hepatic stellate cells,METHODS AND RESULTS Fifty male Sprague-Dawley rats,weighing(180±20)g,wererandomized into five groups(control group,modelgroup,and three losartan treated groups),inwhich all rats were given the subcutaneousinjection of 40% CCl<sub>4</sub>(every 3 days for 6 weeks)except for rats of control group.Rats of losartan-treated groups were treated with losartan(20 mg/kg,10 mg/kg,5 mg/kg,daily gavage),After 6weeks liver tissue and serum samples of all ratswere examined.Serum hyaluronic acid(HA),procollagen typeⅢ(PCⅢ)were detected byradioimmunoassays,van Giesion collagen stainingwas used to evaluate the extracellular matrix of ratswith liver fibrosis.The expression of AT1receptors,transforming growth factor-beta(TGF-β),and alpha-smooth muscle actin(a-SMA)inliver tissue were determined byimmunohistochemical techniques.Compared withmodel group,serum ALT and AST of losartan-treated groups were significantly reduced(t=4.20,P【0.01 and t=4.57,P【0.01).Serum HAand PCⅢalso had significant differences(t=3.53,P【0.01 and t=2.20,P【0.05).Thedegree of fibrosis was improved by losartan and correlated with the expressions of AT1 receptors,TGF-β,and α-SMA in liver tissue.CONCLUSION AT1 receptor antagonist,losartan,could limit the progression of the hepatic fibrosisinduced by CCl<sub>4</sub>.The mechanism may be related tothe decrease in the expression of AT1 receptorsand TGF-β,ameliorating the injury of hepatocytes;activation of local renin-angiotensin system mightrelate to hepatic fibrosis;and during progressionof fibrosis,activated hepatic stellate cells mightexpress AT1 receptors. 展开更多
关键词 liver cirrhosis/drug therapy RENIN-ANGIOTENSIN system ANGIOTENSIN type 1 receptor antagonist LOSARTAN
下载PDF
Effect evaluation of interleukin-1 receptor antagonist nanoparticles for mesenchymal stem cell transplantation 被引量:3
15
作者 Xiao-Lei Shi Wei Zhu +5 位作者 Jia-Jun Tan Jiang-Qiang Xiao Lin Zhang Qian Xu Zheng-Liang Ma Yi-Tao Ding 《World Journal of Gastroenterology》 SCIE CAS 2013年第12期1984-1991,共8页
AIM: To study the efficacy of marrow mesenchymal stem cells (MSCs) transplantation combined with interleukin-1 receptor antagonist (IL-1Ra) for acute liver failure (ALF). METHODS: Chinese experimental miniature swine ... AIM: To study the efficacy of marrow mesenchymal stem cells (MSCs) transplantation combined with interleukin-1 receptor antagonist (IL-1Ra) for acute liver failure (ALF). METHODS: Chinese experimental miniature swine were randomly divided into four groups (n = 7), and all animals were given D-galactosamine (D-gal) to induce ALF. Group A animals were then injected with 40 mL saline via the portal vein 24 h after D-gal induction;Group B animals were injected with 2 mg/kg IL-1Ra via the ear vein 18 h, 2 d and 4 d after D-gal induction; Group C received approximately 1 × 108 green fluorescence protein (GFP)-labeled MSCs (GFP-MSCs) suspended in 40 mL normal saline via the portal vein 24 h after D-gal induction; Group D animals were injected with 2 mg/kg IL-1Ra via the ear vein 18 h after D-gal induction, MSCs transplantation was then carried out at 24 h after D-gal induction, and finally 2 mg/kg IL-1Ra was injected via the ear vein 1 d and 3 d after surgery as before. Liver function, serum inflammatory parameters and pathological changes were measured and the fate of MSCs was determined.RESULTS: The optimal efficiency of transfection (97%) was achieved at an multiplicity of infection of 80, as observed by fluorescence microscopy and flow cytometry (FCM). Over 90% of GFP-MSCs were identified as CD44+ CD90+ CD45-MSCs by FCM, which indicated that most GFP-MSCs retained MSCs characteristics. Biochemical assays, the levels of serum inflammatory parameters and histological results in Group D all showed a significant improvement in liver injury compared with the other groups (P < 0.05). The number of GFP-MSCs in Group D was also greater than that in Group B, and the long-term cell proliferation rate was also better in Group D than in the other groups.CONCLUSION: MSCs transplantation is useful in ALF, IL-1Ra plays an important role in alleviating the inflammatory condition, and combination therapy with MSCs transplantation and IL-1Ra is a promising treatment for ALF. 展开更多
关键词 INTERLEUKIN-1 RECEPTOR antagonist MESENCHYMAL stem cells Cell TRANSPLANTATION Acute liver failure INFLAMMATORY environment
下载PDF
Synthesis and antitumor activity of nitric oxide releasing derivatives of AT1 antagonist 被引量:2
16
作者 Yan Chun Zhang Jin Pei Zhou Xiao Ming Wu Wei Hong Pan 《Chinese Chemical Letters》 SCIE CAS CSCD 2009年第3期302-305,共4页
A series of novel nitric oxide-donating derivatives (7a-e, 8a-e) were synthesized by coupling furoxan and nitric oxide with irbesartan analogue and their cytotoxicity against BEL7402 cells in vitro were evaluated by... A series of novel nitric oxide-donating derivatives (7a-e, 8a-e) were synthesized by coupling furoxan and nitric oxide with irbesartan analogue and their cytotoxicity against BEL7402 cells in vitro were evaluated by MTT method. It was found that 8c exhibits the most cytotoxic activities with ICso value of 12.5 μmol/L. The hybrids of AT1 antagonist and nitric oxide donor appear to have beneficial effects on antitumor. 展开更多
关键词 AT1 antagonist Nitric oxide-donating ANTITUMOR SYNTHESIS
下载PDF
Study on Immunoregulation by Interleukin-1 ReceptorAntagonist in NZB/W F_1 Mice 被引量:1
17
作者 孙汉英 刘文励 +3 位作者 邵静芳 徐慧珍 肖侃艳 沈关心 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 1997年第1期18-20,24,共4页
The immunoregulating effect of Interleukin-1-receptor antagonist (ILlra ) in lupus-like NZB/W F, mice was investigated to find possible approach to prevent lupus nephritis. 12 female NZB/W F1 mice of 13 weeks were ran... The immunoregulating effect of Interleukin-1-receptor antagonist (ILlra ) in lupus-like NZB/W F, mice was investigated to find possible approach to prevent lupus nephritis. 12 female NZB/W F1 mice of 13 weeks were randomly divlded into 2 groups. Each mouse in the treated group was intraperitoneally injected wlth IL-lra once every 2 weeks for 3 times at the dosage of 100μg each time,while the control group was given injection of 0.1 ml normal saline. All the mice were killed at the age of 9 months and the irnmunologic function was examined.Results showed that this dosage could not completely prevent the development of lupus nephritis, but the renal damage was alleviated and the urine protein was decreased. Moreover, it could improve the immunofunction by significantly reducing the levels of serum IL-1 and obviously increase the activities of NK celIs and IL-2 induced by ConA in mononuclear cells of spleen. There was no significant difference in the levels of serum IL-6 and TNF-α between the treated group and control group. It is concluded that IL-lra has certain regulatory effect on the immunologic function of lupus-like NZB/W F, mice. 展开更多
关键词 interleukin-1 receptor antagonist systemic lupus erythematosis immune system
下载PDF
Medical therapy for clinical benign prostatic hyperplasia:α1 Antagonists,5α reductase inhibitors and their combination 被引量:4
18
作者 Cheuk Fan Shum Weida Lau Chang Peng Colin Teo 《Asian Journal of Urology》 2017年第3期185-190,共6页
Medical therapy for clinical benign prostatic hyperplasia(BPH)has advanced significantly in the last 2 decades.Many new a1 antagonists and 5a reductase inhibitors(5ARi)are now commercially available.The practicing uro... Medical therapy for clinical benign prostatic hyperplasia(BPH)has advanced significantly in the last 2 decades.Many new a1 antagonists and 5a reductase inhibitors(5ARi)are now commercially available.The practicing urologist must decide on the most appropriate medication for his patients,taking into consideration various factors like efficacy,dosing regime,adverse effects,cost,patient’s socioeconomic background,expectations,drug availability and his own clinical experience.The use of combination therapy added further to the complexity in clinical judgment when prescribing.We highlight some of the key points in prescribing a1 antagonists,5ARi and their combination,based on our viewpoints and experience as urologists in an Asian clinical setting. 展开更多
关键词 5αReductase inhibitors Adrenergicα1 receptor antagonists Drug therapy COMBINATION Prostatic hyperplasia
下载PDF
Design,synthesis and biological estimation of 1-(benzoxazole-2-yl)piperazine and 4-(benzoxazole-2-yl)piperidine derivatives as potentialα_1-AR antagonists 被引量:1
19
作者 Jia Bin Li Lin Xia +2 位作者 Bin Wu Tao Wang Zhen Zhou Jiang 《Chinese Chemical Letters》 SCIE CAS CSCD 2008年第10期1193-1195,共3页
Two series of 1-(benzoxazole-2-yl)piperazine (Sa-i) and 4-(benzoxazole-2-yl)piperidine compounds (10a-i) were designed, synthesized and evaluated for their α1-AR antagonistic activities. Biological assay in v... Two series of 1-(benzoxazole-2-yl)piperazine (Sa-i) and 4-(benzoxazole-2-yl)piperidine compounds (10a-i) were designed, synthesized and evaluated for their α1-AR antagonistic activities. Biological assay in vitro indicated that 10h showed slightly stronger α1-AR antagonistic activity to that of our lead compound 1. 展开更多
关键词 BPH α1-AR antagonists Benzoxazole PIPERIDINE PIPERAZINE
下载PDF
Correlation of polymorphism in the interleukin-1 receptor antagonist gene intron 2 with alcoholic liver disease 被引量:1
20
《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2005年第1期41-45,共5页
关键词 INTERLEUKIN-1 receptor antagonist GENE POLYMORPHISM ALCOHOLIC liver disease
下载PDF
上一页 1 2 39 下一页 到第
使用帮助 返回顶部